Identifying germline APOBEC3B deletion and immune phenotype in Korean patients with operable breast cancer.

Se Hyun KimSoomin AhnKoung Jin SuhYu Jung KimSo Yeon ParkEunyoung KangEun-Kyu KimIn Ah KimSumin ChaeMurim ChoiJee Hyun Kim

Published in: Breast cancer research and treatment (2020)

We identified germline APOBEC3B deletion in 9.7% of Korean patients with operable breast cancer. The relationship between A3Bdel/del genotype and high TILs suggests that patients carrying this genotype could be potential candidates for immunotherapy.

Keyphrases

end stage renal disease
ejection fraction
chronic kidney disease
newly diagnosed
prognostic factors
peritoneal dialysis
risk assessment
oxidative stress
young adults
dna damage
human health